![]() |
|
|
Vol. 12, Issue 9, 2730-2741, September 2001

*Department of Pathology, CMU, University of Geneva, 1211 Geneva 4, Switzerland; and
Department of Cell Biology, University
of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104
| |
ABSTRACT |
|---|
|
|
|---|
To evaluate whether
-smooth muscle actin (
-SMA) plays a role
in fibroblast contractility, we first compared the contractile activity
of rat subcutaneous fibroblasts (SCFs), expressing low levels of
-SMA, with that of lung fibroblasts (LFs), expressing high levels of
-SMA, with the use of silicone substrates of different stiffness
degrees. On medium stiffness substrates the percentage of cells
producing wrinkles was similar to that of
-SMA-positive cells in
each fibroblast population. On high stiffness substrates, wrinkle
production was limited to a subpopulation of LFs very positive for
-SMA. In a second approach, we measured the isotonic contraction of
SCF- and LF-populated attached collagen lattices. SCFs exhibited 41%
diameter reduction compared with 63% by LFs. TGF
1 increased
-SMA
expression and lattice contraction by SCFs to the levels of LFs;
TGF
-antagonizing agents reduced
-SMA expression and lattice
contraction by LFs to the level of SCFs. Finally, 3T3 fibroblasts
transiently or permanently transfected with
-SMA cDNA exhibited a
significantly higher lattice contraction compared with wild-type 3T3
fibroblasts or to fibroblasts transfected with
-cardiac and
- or
-cytoplasmic actin. This took place in the absence of any change in
smooth muscle or nonmuscle myosin heavy-chain expression. Our results
indicate that an increased
-SMA expression is sufficient to enhance
fibroblast contractile activity.
| |
INTRODUCTION |
|---|
|
|
|---|
Early during healing of an open wound, resident dermal fibroblasts
proliferate from the wound margin and migrate into the provisional
matrix composed of a fibrin clot. About 1 week after wounding, the
provisional matrix is replaced by neo-formed connective tissue, known
as granulation tissue, essentially composed of small vessels,
extracellular matrix, and fibroblastic cells that become activated and
modulate into myofibroblasts. The main feature of myofibroblasts is
represented by an important contractile apparatus similar to that of
smooth muscle (Gabbiani et al., 1971
), and in particular by
the neo-expression of
-smooth muscle actin (
-SMA), the
actin isoform typical of vascular smooth muscle cells (Skalli et
al., 1986
). Myofibroblasts are recognized to play a central role
in closing the wound tissue, through their capacity to produce a strong
contractile force (for review see Grinnell, 1994
; Rønnov-Jessen et al., 1996
; Powell et al., 1999
; Serini and
Gabbiani, 1999
), possibly generated within stress fibers, similar to
those present in cultured fibroblasts (Skalli et al., 1986
;
Serini and Gabbiani, 1999
). Because wound contraction takes place when
de novo expressed
-SMA is incorporated in stress fibers (Darby
et al., 1990
), it has been suggested that this actin isoform
plays an important role in granulation tissue contraction (for review
see Serini and Gabbiani, 1999
). Although stress fibers have been
proposed to function as contractile organelles (Burridge, 1981
; Katoh
et al., 1998
) and their presence has been correlated with
the production of isometric tension (Harris et al., 1981
),
at present direct evidence of a functional role of
-SMA in
fibroblast contraction is lacking. Here, we have used several in vitro
models and approaches in order to test the possible correlation between
the expression of
-SMA and the contractile activity of fibroblastic cells.
It is more and more accepted that fibroblastic cells are heterogeneous
(for review see Komuro, 1990
; Serini and Gabbiani, 1999
). A marker of
fibroblast heterogeneity is the differential expression of cytoskeletal
proteins, including actin isoforms (Sappino et al., 1990
).
When grown in culture, fibroblasts from different organs constantly
modulate into myofibroblast-like cells but show various degrees of
-SMA expression (Xu et al., 1997
; Dugina et
al., 1998
). We have exploited this heterogeneity to compare the
contractile potential of cultured rat subcutaneous fibroblasts (SCFs),
expressing low levels of
-SMA, with lung fibroblasts (LFs),
expressing high levels of
-SMA (Xu et al., 1997
; Dugina
et al., 1998
). In addition, we have enhanced the expression
of
-SMA in SCFs by treatment with transforming growth factor
(TGF
; Desmoulière et al., 1993
; Rønnov-Jessen and
Petersen, 1993
). Conversely, we have reduced
-SMA expression in LFs
by blocking the activity of endogenous TGF
1 with a specific
neutralizing antibody, the soluble TGF
-receptor type II (TGF
-sR)
or the recombinant ED-A fragment (rED-A) of cellular fibronectin (FN;
Serini et al., 1998
). Finally, in a direct approach to
induce expression of
-SMA, we have transiently and stably
transfected Swiss 3T3 fibroblasts with
-SMA cDNA.
To determine contractility on a single cell level, we used a
modification of the silicone elastomer substrate assay originally developed by Harris et al. (1980)
, combined with a
modification of the force quantification method introduced by Lee
et al. (1994)
. The contractility of whole cell populations
was quantified with the use of stress-released collagen lattices
(Mochitate et al., 1991
; Tomasek et al., 1992
;
Grinnell et al., 1999b
). Our results indicate a correlation
between the level of
-SMA expression and fibroblast contraction. In
addition, we provide new insights into the interdependence of TGF
1
and ED-A FN in regulating myofibroblast contractile activity.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture
Fibroblasts from explants of rat subcutaneous and lung tissues
and 3T3 fibroblasts were cultured as described previously
(Desmoulière et al., 1992
). Experiments with primary
cell cultures between passage 4 and 8 were performed in MEM (Life
Technologies AG, Basel, Switzerland), supplemented with 10% FCS or
with 4% Monomed, a defined medium in which fibroblasts do not
replicate (Commonwealth Serum Laboratories, Melbourne, Australia;
Serini et al., 1998
). TGF
1 (R&D Systems, Inc.,
Minneapolis, MN) or TGF
2 (10 ng/ml; gift from Dr. A. Cox, Novartis,
Basel, Switzerland), TGF
-sR (Lin et al., 1995
; 0.1-100
ng/ml, gift of Biogen Inc., Cambridge, MA, Komesli et al.,
1998
) and TGF
1-neutralizing antibody (0.01-10 µg/ml, R&D Systems)
were added for 5 d to the culture medium. rED-A (gift of Biogen
Inc.) was incorporated at 300 µg/ml (Serini et al., 1998
)
into collagen lattices (see below).
Deformable Silicone Substrates and Single Cell Force Measurement
Deformable silicone substrates were essentially prepared as
described previously (Harris et al., 1980
). Fifty
microliters of silicone (poly dimethyl siloxane; 30,000 centistokes;
Dow Corning, Midland, MI) were deposited onto a 35-mm round glass
coverslip, which was placed into a six-well plate and centrifuged at
1000 rpm for 2 min with the use of a swinging rotor. The silicone
surface was then cross-linked by passing it through a Bunsen flame. A rubber ring was sealed with a polyvinylsiloxane dental resin (President MicroSystems; Coltène, Altstätten, Switzerland) on the
coverslip, resulting in a small chamber containing at the bottom the
cross-linked silicone. Silicone substrates were equilibrated with 0.1%
gelatin in Tris-HCl buffer, pH 8.4, sterilized by UV light exposure,
and left overnight in the incubator at 37°C.
To compare SCFs and LFs for their capacity to produce wrinkles and for
-SMA expression, after preliminary experiments the flaming time of
1 s was used; this restricted wrinkle formation to fibroblasts
with high contractile force (see RESULTS). Cells (30,000) were seeded
onto the silicone and grown for 5 d in MEM/10% FCS (±TGF
).
The percentage of cells producing wrinkles was related to the number of
-SMA-positive cells grown in parallel on culture dishes (30,000 cells/30 mm dish; Nunc, Life Technologies), as quantified by
immunofluorescence. To visualize wrinkling and
-SMA expression
simultaneously, fibroblasts were directly fixed on the silicone
substrates and immunostained (see below).
-SMA-positive and
wrinkling fibroblasts were calculated as percentage of total cells with
the use of a program after manual cell selection on a computer screen
(KS400; Carl Zeiss Inc., Jena, Germany). Ten random regions of interest
were analyzed per experiment (~25 cells/field), and at least 5 experiments were performed.
To quantify the force exerted by individual fibroblasts, we produced
deformable silicone substrates with different degrees of mechanical
resistance by modulating the flaming time (0.5-4 s). Before seeding
cells, these substrates were mechanically wrinkled with a deflecting
flexible microneedle with a stiffness between 90 and 110 nN/µm (Lee
et al., 1994
; Fray et al., 1998
). A second stiff
needle (
50 µN/µm) was used to fix the substrate at a distance of
200 µm, simulating the substrate-pinching of bipolar cells. The force
required to produce first wrinkles on different silicone substrates was
calculated from the flexible needle stiffness (µN/µm) and
deflection (µm; Oliver et al., 1995
) on 15 different
regions. LFs were then grown on these substrates and immunostained, and the percentage of wrinkling cells of
-SMA-positive LFs and of
-SMA-negative LFs were calculated separately as described above.
Stressed Collagen Lattice Contraction Assay
To correlate the contractile potential and the level of
-SMA
expression in cell populations, fibroblasts were grown in attached (Grinnell, 1994
) collagen type I lattices (0.75 mg/ml) as previously described (Tomasek et al., 1992
; Pilcher et al.,
1994
; Rayan et al., 1996
). Populations were initiated with
0.25-10.0 × 105 cells/ml collagen,
depending on the presence of serum, the cell type, and the
myofibroblastic differentiation, and cultured for 5 d. Lattices
populated with transiently transfected 3T3 fibroblast were cultured for
2 d in order to work at their maximum transgene activity,
determined by immunofluorescence and Western blotting (see below). For
contraction measurement, lattices were released with the use of a
syringe and lattice diameter was measured under dark-field illumination
after 5, 10, and 30 min. Only maximum contraction after 30 min is
presented. A minimum of five lattices was assayed per experimental
condition, mean values were calculated, and lattice diameter reduction
was normalized to the lattice diameter before release (= % contraction). Collagen lattices were then digested, and cells were
harvested and counted as previously described (Vaughan et
al., 2000
). Contraction results were only considered if cell
concentration ranged between 5.7 × 104 and
6.3 × 104 cells/lattice at the time of
release. All experiments were performed at least five times.
Antibodies and Immunofluorescence Microscopy
Cells grown in collagen lattices and on plastic culture dishes
were fixed with 3% paraformaldehyde (PFA) in PBS containing 1 mM
CaCl2 (PBS/Ca2+) for 15 min
and permeabilized with 0.2% Triton X-100 (TX-100) in
PBS/Ca2+ for 5 min. To test myosin expression,
cells were fixed with 100% ethanol for 30 s. To simultaneously
observe wrinkles and
-SMA-positive stress fibers, silicone-coated
coverslip chambers were transferred rapidly from culture medium in
prewarmed (37°C) 3% PFA in PBS/Ca2+, fixed for
15 min at 37°C, rinsed with PBS, permeabilized with 0.2% TX-100 in
PBS/Ca2+ for 5 min, and immunostained. Care was
taken that the silicone surface remained wet for the whole procedure.
Cells were stained for
-SMA (anti-
SM-1, IgG2a mAb; Skalli
et al., 1986
), F-actin (Phalloidin-Alexa 488, Molecular
Probe, Eugene, OR),
-cytoplasmic (
74, rbAb; Yao et
al., 1995
),
-sarcomeric actin (SR-1, IgM mAb; Dako),
-actins
and
-SMA (AAL-20, rbAb), ED-A FN (IST-9, IgG1 mAb, gift from Dr. L. Zardi, National Institute for Cancer Research, Laboratory of Cell
Biology, Genoa, Italy; Borsi et al., 1987
; Carnemolla
et al., 1987
), VSV-G-tag (anti-VSV-G-tag, rbAB, a gift of
Dr. J.-C. Perriard, ETH, Zürich, CH), the heavy chains (HC) of
SMM and NMM (anti-SMMHC and anti-NMMHC, rbAbs; Benzonana et
al., 1988
) and DNA (DAPI). As secondary antibodies TRITC- and
FITC-conjugated goat anti-mouse subclasses IgG1 and IgG2a (Southern
Biotechnology Associates Inc., Birmingham, AL), IgG, IgM, and goat
anti-rabbit antibodies (Jackson ImmunoResearch Laboratories, West
Grove, PA) were used. Cells on plastic and collagen lattices were
mounted in polyvinyl alcohol (Lennette, 1978
); cells on silicone were
covered with PBS, and chambers were sealed with a coverslip with the
use of dental resin (President MicroSystems). All samples were observed
with an oil immersion objective (Plan-Neofluar 40×/1.3, Ph3; Zeiss) on
an Axiophot Zeiss microscope (Zeiss). Digital images were taken with a
digital color camera (Coolview; Photonic Science Ltd., Millham, UK) and
grabber software (ImageAccess V2.04K; Imagic Bildverarbeitung AG,
Glattbrugg, Switzerland).
Inside three-dimensional collagen lattices the number of
-SMA-positive fibroblasts was automatically detected by a color thresholding routine (KS400; Zeiss) on images taken with a 20× objective (Zeiss) and related to the total cell number, determined by
DAPI staining. Mean values were calculated from five independent experiments, analyzing five fields per lattice and five lattices per
condition. All digital images were processed for printing with the use
of Adobe Photoshop and printed with a digital Fujifilm Pictrography
4000 printer (Fuji Photo Film GmbH, Düsseldorf, Germany).
Western Blot Analysis
Fibroblast grown on plastic culture dishes were sampled as
previously described (Chaponnier et al., 1995
). Fibroblasts
harvested from collagen lattices (see above) were suspended in sample
buffer (1.25 × 106 cells/ml), sonicated,
and boiled for 3 min. Protein content was determined with the use of a
1 µl protein assay (dotMetric; Geno Technology Inc., St.
Louis, MO). Equal amounts of total proteins (5-10 µg) were loaded to
10% or 7% SDS-minigels (Bio-Rad Laboratories AG, Glattbrugg,
Switzerland), separated by PAGE (Laemmli, 1970
), and transferred to
nitrocellulose membrane (Protran, BA85; Schleicher & Schuell, Dassel,
Germany; Towbin et al., 1979
). Membranes were then probed
with the same primary antibodies used for immunofluorescence. Total
actin was probed with the use of a mixture of antibodies against the
different isoforms (see above). Incubations were followed by secondary
antibodies goat anti-mouse IgG and goat anti-rabbit IgG, respectively,
conjugated with horseradish-peroxidase (HRP; Jackson ImmunoResearch
Laboratories). Signals were detected by ECL chemiluminescence
(Amersham, Rahn AG, Zürich, Switzerland). Bands were digitized
with a scanner (Arcus II; Agfa, Köln, Germany) and the ratio
between all band densities of 1 blot was calculated by computer
software (ImageQuant V3.3; Molecular Dynamics, Sunnyvale, CA). Relative
-SMA expression was normalized to the respective value for total
actin in primary cells; in transfected cells VSV-G-tag expression was
normalized to vimentin.
Actin Constructs and Transfection
The actin constructs used in our experiments were described by
von Arx et al. (1995)
and their sorting in several cell
types was reported previously (Mounier et al., 1997
). For
transient and stable transfections, we used a pCMV
vector (Clontech
Laboratories AG, Basel, CH), in which the neomycin gene was cloned in
EcoRI and in which the
-galactosidase gene was replaced
by full-length cDNA encoding rat
-SMA, human
- and
-cytoplasmic actins, and chicken
-cardiac muscle actin. The 3'
untranslated region (3'UTR) of actin isoforms was replaced by cDNA
coding for the vesicular stomatitis virus G-protein (VSV-G; Soldati and
Perriard, 1991
), thus tagging the actins on C terminus. 3T3 fibroblasts
were transfected with the use of FuGene 6 (Boehringer Mannheim AG,
Mannheim, Germany) according to the manufacturer's protocol. To
produce stable clones, transfected cells were split after 24 h and
resuspended (1:50) in culture medium containing 1.5 mg/ml selection
factor G418 (Promega, Madison, WI). After 7 d, colonies of
10
cells were isolated with the use of a 5-mm metal ring, trypsinized, and
subcloned under G418 selection. Each clone was tested for expression of
the transfected protein by Western blotting and by immunostaining for
VSV-G-tag and the respective actin isoform.
Statistical Analysis
Numerical results are presented as the means ± SD of all
experiments. Mean values were tested by a two-tailed heteroscedastic Student's t test. Differences were considered to be
statistically significant at values of p
0.01. p values
0.005 were indicated by an asterisk (*) and with a double-asterisk (**)
for p
0.001. The positive linear correlation between fibroblast
contraction and
-SMA expression was statistically tested by
calculating the square of the Pearson correlation product
(r2 value).
| |
RESULTS |
|---|
|
|
|---|
Wrinkle Formation on Deformable Silicone Substrates Correlates with
-SMA Expression
SCFs and LFs, expressing different levels of
-SMA (Figure
1A; Western blot), exhibited different
proportions of cells deforming the surface of 1-s flamed silicone
(Figure 1). Only 20% of the fibroblasts derived from subcutaneous
tissue produced wrinkles on the silicone film after 3 d (Figure
1A). The proportion of wrinkle-producing cells correlated with the
proportion of
-SMA-positive SCFs (18%) determined after
immunofluorescence staining on plastic dishes. When rat LFs were
tested, 79% produced wrinkles, and 80% were
-SMA-positive. To
further investigate the correlation between contracting cells and
-SMA-positive cells, SCFs were treated for 3 d with 10 ng/ml
TGF
1, previously shown to increase
-SMA expression in cultured
fibroblasts (Desmoulière et al., 1993
; Rønnov-Jessen
and Petersen, 1993
). TGF
1 significantly enhanced the proportion of
SCFs producing wrinkles on silicone to 52%. Concomitantly, 53% of
SCFs expressed
-SMA on plastic. TGF
2 caused similar effects (data
not shown). TGF
treatment of LFs did not enhance wrinkling and
-SMA expression significantly. The correlation factor between
the number of wrinkle-producing cells and the number of
-SMA-positive cells was r2 = 0.99. TGF
did not induce the expression of SMMHC. When
-SMA was stained
(Figure 2B) on silicone substrates (1 s
flaming), in which wrinkles were preserved (Figure 2A), it became
evident that practically only
-SMA-positive cells deformed the
silicone surface (Figure 2D). Fixation did not change the proportion of wrinkle-producing cells (Figure 1, A and B). Both, nonwrinkling
-SMA-negative and wrinkling
-SMA-positive fibroblasts exhibited a well-spread morphology and an F-actin-positive cortex. In
-SMA-positive fibroblasts stress fibers were generally more
prominent and more organized in parallel bundles throughout the
cytoplasm compared with
-SMA-negative cells (Figure 2C).
Interestingly, stress fibers appeared to be thinner in fibroblasts on
silicone compared with fibroblasts grown on plastic Petri dishes,
possibly reflecting the different resistance of the two substrates
(Harris et al., 1981
). Quantifying the proportion of
wrinkle-producing cells that were
-SMA-positive on the 1 s-flamed
silicone led to a percentage of 90%, independently of the total number
of
-SMA-positive cells (Figure 1B).
|
|
The stiffness of the silicone substrate surface provided a threshold to
distinguish between contractile, surface-wrinkling cells and less
contractile, nonwrinkling cells. To compare the forces exerted by
single
-SMA-positive and -negative fibroblasts, we produced
silicone substrates with varying stiffness by gradually increasing the
flaming time (Figure 3, bar) and
determined the force required to cause wrinkles in these films.
Increasing substrate stiffness required approximately linearly
increasing wrinkling force and showed little local variance within the
same substrate (
1%). However, the thin silicone film at the
substrate periphery showed significantly higher resistance (18 ± 2%) compared with the central part. Hence, the peripheral 5 mm were
not considered for quantification. When a force of ~1.5 µN was
required, virtually all
-SMA-positive LFs but only 60%
-SMA-negative LFs produced wrinkles (Figure 3). The largest
difference between the percentages of
-SMA-positive and of
-SMA-negative LFs producing wrinkles (89% vs. 16%) was observed
on substrates that required a wrinkling force of ~4.0 µN. By
further increasing the substrate stiffness, i.e., when a force of
~6.0 µN was required, wrinkles were produced essentially by
-SMA-positive and only by <5% of
-SMA-negative LFs. When the
stiffness of the substrate required a wrinkling-force of ~8.5 µN,
27% of
-SMA-positive LFs but none of the
-SMA-negative LFs
were capable of producing wrinkles.
|
Contraction of Fibroblast-populated Collagen Lattices Correlates
with
-SMA Expression
When released from the culture dish after 5 d
fibroblast-populated attached collagen lattices contracted rapidly and
reached maximal contraction after 30 min. The contractile potential of SCF populations, expressing low levels of
-SMA, was again compared with that of LF populations, expressing high amounts of
-SMA. For a
given cell type, the degree of contraction was dependent on the number
of fibroblasts populating the lattice at the time of release. However,
at any comparable cell number, LFs contracted the lattices
significantly more than SCFs. The largest difference was observed at
6 × 104 cells/lattice, where both
populations exhibited maximal contraction. SCFs caused a 41% lattice
contraction compared with a 63% contraction for LFs (Figure
4A). Treating SCFs with 10 ng/ml TGF
1
during 5 d increased lattice contraction to 63%, thereby reaching
the level of LFs. TGF
1-treatment showed no enhancing effect on LF contraction (63%). Again, no differences were observed between the
effects of TGF
1 and TGF
2. In a second approach, the action of
endogenous TGF
was neutralized by applying TGF
-sR to collagen lattices for 5 d (Figure 4A). Increasing the concentration of TGF
-sR in steps of one order of magnitude (1.0-100 ng/ml) reduced LF contraction gradually from 63% to a minimum of 38%, thereby reaching the level of control SCFs. The contractility of SCFs was not
affected by 100 ng TGF
-sR. Similar results were obtained by blocking
TGF
action with a TGF
1-neutralizing antibody in concentrations
between 0.1 and 10 µg/ml for 5 d. These results are in
accordance with the possibility that LFs in collagen lattices maintain
a high level of
-SMA expression by autocrine stimulation with
TGF
.
|
Lattices were digested after contraction experiments, and cellular
proteins were blotted to evaluate
-SMA and total actin levels
(Figure 4B).
-SMA expression was lower in SCF populations compared
with LFs. The level of
-SMA in SCFs was enhanced by TGF
treatment
and reduced in LFs by blocking TGF
effect with TGF
-sR (Figure 4B)
or anti-TGF
1 antibody. The level of total actin remained constant at
all conditions tested. Protein content analysis was complemented by
staining fibroblasts in collagen lattices for
-SMA and F-actin
(Figure 5). When grown in lattices, SCFs
exhibited broader lamellae (Figure 5A) compared with LFs, which were
more elongated and showed prominent stress fibers (Figure 5D). Exposing
SCFs to TGF
increased the proportion of cells expressing
-SMA
from 13 ± 2%-69 ± 4% and lead to moderate cell
elongation. Treatment of LFs with either TGF
-sR (Figure 5E) or
anti-TGF
1 antibody reduced the number of LFs expressing
-SMA from
70 ± 5%-12 ± 2% but did not alter F-actin organization.
Both blocking factors had no significant effect on SCF morphology and
-SMA expression. Generally, the percentage of
-SMA-positive
cells in collagen lattices was ~1.4-fold lower compared with plastic and silicone substrates, possibly reflecting the different substrate compliance (Arora et al., 1999b
).
|
ED-A FN Is Essential for
-SMA Expression and Contraction
of Fibroblast-populated Collagen Lattices
We have recently shown that induction of
-SMA expression by
TGF
depends on the presence of ED-A FN in the extracellular matrix
(Serini et al., 1998
). In the attached collagen lattice model, the levels of endogenous ED-A FN and
-SMA expression at 5 d varied according to the myofibroblastic differentiation
(Figure 5). Control SCFs (Figure 5C) and LFs treated with TGF-sR
secreted low amounts of ED-A FN. In contrast, TGF
-stimulated SCFs
and control LFs (Figure 5F) produced high amounts of ED-A FN, organized into extracellular fibrils and aligned with intracellular F-actin bundles as observed by confocal imaging.
The importance of ED-A FN in mediating TGF
-induced fibroblast
contraction was then tested by adding rED-A to the collagen matrix of
the lattice contraction assay. To exclude effects of plasma factors and
plasma FN, all experiments were performed with the use of Monomed
without medium change during 5 d. Fibroblast-populated collagen
lattices in Monomed contracted similarly (Figure
6A) compared with serum conditions
(Figure 4A). rED-A reduced the contraction of LFs to 38% (LF
control = 60%) but had no effect on SCF lattice contraction
(38%). When fibroblast-populated lattices were simultaneously treated
with rED-A and TGF
, intermediate lattice contraction was obtained:
SCF contraction was lower (50%) when treated additionally with rED-A
compared with TGF
treatment only (59%). Treating LFs simultaneously
with TGF
and rED-A partially rescued lattice contraction (48%)
compared with rED-A alone (38%).
|
Correlation between increased lattice contraction and increased
-SMA
expression was examined by analyzing the amount of
-SMA in the
lattice cells (Figure 6B). The level of total actin was not changed by
the experimental conditions. A correlation factor of
r2 = 0.88 was obtained when
contraction mean values were tested against mean values of
-SMA
levels (Figure 6B), calculated from Western blot quantitative analysis
and normalized to total actin. Immunofluorescence staining of
rED-A-containing lattices and subsequent cell counting revealed a
decrease in the proportion of
-SMA-positive LFs (13 ± 2%)
compared with lattices not containing rED-A (70 ± 4%). LFs
exhibited a similar morphology in rED-A lattices as after
TGF
-blocking experiments (Figure 5E). No changes were noticed regarding the number of
-SMA-positive SCFs (13 ± 2%) and
their morphology after rED-A, similarly to TGF
-sR treatment.
Transfection with
-SMA cDNA Enhances Contraction of 3T3
Fibroblasts
To investigate the direct effect of
-SMA expression on
fibroblast contraction, we transiently and stably transfected Swiss 3T3
fibroblasts with
-SMA cDNA and evaluated their ability to contract
stressed collagen lattices. 3T3 fibroblasts were chosen because of
their high transfection rate (21% in average) compared with primary
fibroblasts (2-5%; Mounier et al., 1999
) and because of
their basal low
-SMA expression (Figure
7A, E). Wild-type 3T3 fibroblasts, grown
in attached collagen lattices or on culture dishes, develop stress
fibers in the presence of serum (Figure 7A) but only ~3-5% of the
cells are
-SMA positive. Transfected
-SMA was predominantly
incorporated into stress fibers as evaluated by double-labeling with
antibodies against
-SMA and against the VSV-G-tag at the actin C
terminus (Figure 7B). Stably transfected
-cardiac (Figure 7D) and
transiently transfected
-cytoplasmic actin were also incorporated
into stress fibers, but the latter occasionally accumulated in
cytoplasmic aggregates if strongly overexpressed, a phenomenon reported
previously for transfected primary cells (von Arx et al.,
1995
; Mounier et al., 1997
). Transfected
-cytoplasmic
actin predominantly localized in lamellipodia and membrane ruffles
(Figure 7C) and sporadically appeared in stress fibers of high
expressing clones. Increased expression of
-SMA after transfection
was demonstrated by Western blotting against VSV-G-tag and
-SMA
(Figure 7E). Transfection with other actin isoforms did not change the
level of
-SMA expression compared with wild-type fibroblasts.
Neither transfected nor wild-type 3T3 fibroblasts expressed SMMHC.
Moreover, transfection did not change the level of NMMHC expression as
tested by immunofluorescence staining and Western blotting.
|
With the use of the collagen lattice assay, wild-type 3T3 fibroblasts
exhibited 26% contraction, which was 1.6-fold lower compared with SCFs
and 2.4-fold lower compared with LFs contraction. 3T3 fibroblast
contraction correlated with transient transfection efficiency
(r2 = 0.92) and was significantly
higher after transfection with
-SMA compared with
-cytoplasmic
actin (132 ± 4%). To minimize variations between different
transfection experiments, we produced 3T3 fibroblast clones stably
expressing
-SMA at different levels and compared their contractile
capacity to clones stably expressing various levels of
-cytoplasmic
and
-cardiac actin (Figure 8). Lattice
contraction showed small linear increase with increasing expression
levels of
-cytoplasmic actin (r2 = 0.9) compared with wild-type fibroblasts; after transfection with
-cardiac actin, linear increasing contraction
(r2 = 0.88) was slightly but
significantly more important than after transfection of
-cytoplasmic
actin. Transfection of
-SMA (r2 = 0.79) clearly promoted the highest contraction at comparable expression
levels (Figure 8).
|
| |
DISCUSSION |
|---|
|
|
|---|
In addition to be a well-accepted marker of myofibroblast
differentiation,
-SMA has been suggested to play a role in the production of contractile force during wound healing and
fibrocontractive diseases (for review see Serini and Gabbiani, 1999
).
Several works have investigated this possibility at the cellular level
(Arora and McCulloch, 1994
; Vaughan et al., 2000
); however,
such function has remained not well established. Our study, exploring
the relationship between the level of
-SMA expression in cultured
fibroblasts and their efficiency to contract deformable silicone
substrates and stress-released collagen gels, shows (1) a significantly
higher contraction of LFs, expressing high levels of
-SMA, compared with SCFs, expressing low levels of
-SMA; (2) an enhancement of
contractile activity in SCFs treated by TGF
concomitant with an
increase of
-SMA expression. Inversely, decreasing
-SMA
expression by blocking the effect of endogenous TGF
with specific
antibodies, TGF
-sR, or rED-A correlates with a reduction of LFs
contractile activity; (3) a clear increase of contraction in 3T3
fibroblasts stably and transiently transfected with
-SMA cDNA
compared with nontransfected cells or cells transfected with
-cardiac,
-cytoplasmic, and
-cytoplasmic actin cDNA, in the
absence of changes in the expression of SMMHC and NMMHC. Taken
together, these results indicate that
-SMA expression is crucial in
determining the extent of in vitro fibroblast contractile activity.
To assess the contractile potential of fibroblast populations we
measured the isotonic contraction of attached collagen gels. Isometrically stressed lattices are a more appropriate model of myofibroblast-populated granulation tissue during wound contraction compared with mechanically unloaded floating lattices (Grinnell, 1994
).
Isometric tension has been shown to be important for the development of
myofibroblastic contractile features such as stress fibers (Burridge,
1981
; Tomasek et al., 1992
; Katoh et al., 1998
; Grinnell et al., 1999a
) and
-SMA expression in collagen
lattices (Arora et al., 1999b
). To test whether
individual
-SMA-positive fibroblasts contract more efficiently than
-SMA-negative cells under identical conditions, we used a
modification of the wrinkling silicone elastomer assay, originally
developed by Harris et al. (1980)
, which is particularly
useful in order to visualize overall cell contractile forces. We show
here a direct correlation between
-SMA expression and the
contractile efficiency of individual fibroblasts by improving the assay
with an immunostaining technique that allows the examination of
cytoskeletal features and silicone substrate wrinkles in the same cell.
By modulating the cross-linking process of the silicone surface, we
have generated a range of elastomers with increasing stiffness and
determined the forces required to wrinkle these substrates. Wrinkling
forces of the same magnitude have been measured for human dermal
fibroblasts, with the use of latex bead displacement assays, but were
restricted to a silicone film with low stiffness in order to provide a
full bead position recovery (Fray et al., 1998
). It is
conceivable that wrinkle-producing fibroblasts exert only the minimum
force necessary to deform these weak surfaces; therefore, the use of elastomers with gradually increasing stiffness is crucial to determine their maximum contractile potential. Highly compliant elastomers have
been wrinkled by a large proportion of
-SMA-negative fibroblasts consistent with the wrinkling capability of numerous cell types (Lee
et al., 1994
; Oliver et al., 1995
). With the use
of stiffer substrates, we determined a threshold of ~4 µN that
discriminates between these relatively weak traction forces and higher
contractile forces (Roy et al., 1999
); this threshold is
only surpassed by
-SMA-positive fibroblasts. Consequently,
expression of
-SMA considerably increases contractile activity but
is not mandatory for cells to exert forces on a low level.
In a further attempt to control the relationship between
-SMA
expression and fibroblast contractile activity, we modulated the level
of
-SMA expression in our cell populations. Among cytokines implicated in myofibroblast differentiation, TGF
has been proven to
directly induce
-SMA expression in vivo and in vitro
(Desmoulière et al., 1993
; Rønnov-Jessen and
Petersen, 1993
). A series of studies with the use of free-floating
collagen gels reported TGF
-induced fibroblast contraction, but did
not consider the expression of
-SMA (Montesano and Orci, 1988
;
Finesmith et al., 1990
; Tingstrom et al., 1992
;
Pena et al., 1994
; Riikonen et al., 1995
;
Levi-Schaffer et al., 1999
) with two exceptions (Arora and
McCulloch, 1994
; Kurosaka, 1995; 2154). However, it was shown recently
that the mechanisms of mechanically unloaded free-floating gel
reduction considerably differ from stressed gel contraction (for review see Grinnell, 2000
). Other studies reported a relationship between increased isometric tension in attached collagen gels and increased
-SMA expression after treating fibroblasts with TGF
, but did not
release these gels to test isotonic contraction (Kurosaka et
al., 1998
; Arora et al., 1999b
). Here we show
that increasing isotonic contraction of mechanically loaded collagen
lattices by TGF
corresponds to an increase of
-SMA expression in
SCFs. Inversely, blocking the effect of TGF
with specific
antibodies, with TGF
-sR or with rED-A reduced
-SMA expression of
LFs and concomitantly lattice contraction. These experiments are
compatible with the existence of a TGF
autocrine loop, maintaining
myofibroblast differentiation and contractile activity (Shi et
al., 1996
; Schmid et al., 1998
) and are consistent with
similar findings of Vaughan et al. (2000)
.
The results of rED-A experiments further suggest a functional role of
the ED-A FN splice variant in fibroblast contraction. The expression of
ED-A FN in healing wounds (Ffrench-Constant et al., 1989
;
Brown et al., 1993
) precedes the appearance of
-SMA-positive myofibroblasts and is essential to mediate
TGF
1-induced
-SMA expression (Serini et al., 1998
).
The mechanism of specific antibodies and of TGF
-sR action on TGF
appears obvious (Komesli et al., 1998
); however, the
mechanism through which rED-A inhibits TGF
-mediated
-SMA
expression is at present unclear. Because antibodies specific against
ED-A FN exert similar effects, rED-A seems to prevent the interaction
between fibroblasts and ED-A FN, a possible outside-in signal for
myofibroblast differentiation. In addition to serving as a signal, ED-A
FN may play a mechanical role by providing efficient cell-matrix
attachment, which is important for transmitting intracellular contraction to the matrix (Racine-Samson et al., 1997
;
Imanaka-Yoshida et al., 1999
; Roy et al., 1999
).
Further studies are needed to understand the mechanism of this ED-A FN activity.
Strong evidence of direct correlation between the level of
-SMA
expression and fibroblast contractility is provided by transfection of
-SMA cDNA into 3T3 fibroblasts. Nontransfected fibroblasts also
contract collagen gels, but exert considerably lower forces compared
with
-SMA-positive fibroblasts, consistent with the wrinkling
capacity of
-SMA-negative cells on compliant elastomers. Downregulation of
-SMA expression by antisense mRNA has been previously shown to provoke an increase in cell migratory activity, possibly mediated through a decrease in cell-matrix adhesion sites (Rønnov-Jessen and Petersen, 1993
). This possibility is in accordance with the observation that significantly larger focal contacts are
present in
-SMA-positive LFs compared with SCFs (Dugina et al., 1998
). Further studies should concentrate on the subcellular mechanisms through which
-SMA increases fibroblast contractile activity and in particular investigate whether transfected
-SMA increases induces the formation of specialized focal contacts, typical
for
-SMA-positive myofibroblasts (Dugina et
al., 1998
; Vaughan et al., 2000
). For this purpose the
use of embedded fluorescent beads in elastic polyacrylamide substrates
(Pelham and Wang, 1997
) in conjunction with detailed computer analysis (Dembo and Wang, 1999
; Pelham and Wang, 1999
) will be necessary. This
technique can also allow to examine whether
-SMA expression mediates
more efficient contraction by increasing the absolute contractile force
or by optimizing the spatial distribution of several subcellular forces.
Transfection with
-SMA increased fibroblast contractility in the
absence of SMMHC expression, in agreement with the recent demonstration
of efficient smooth muscle cell contraction in SMMHC knockout mice
(Morano et al., 2000
) and notably without increasing NMMHC
expression. Furthermore, TGF
enhances contractile activity of SCFs
without changing SMMHC or NMMHC expression. Further studies are needed
to determine whether enhanced
-SMA expression influences
other structural proteins that are involved in cell contraction in an
isoform-specific manner, such as tropomyosin (Schevzov et
al., 1993
), caldesmon (Bretscher and Lynch, 1985
), calponin
(Gimona et al., 1992
), SM22 (Gimona et al.,
1992
), and gelsolin (Arora et al., 1999a
) or whether
it affects regulatory events, including myosin light-chain
phosphorylation, small GTPase activation, and calcium signaling (Parizi
et al., 2000
). The 3'UTRs of
-cardiac and
-cytoplasmic
actin have been suggested to facilitate actin isoform sorting in the
cytoplasm by localizing to different subcellular compartments
(Kislauskis et al., 1993
) and the 3'UTR of
-tropomyosin
has been shown to exert functional tumor suppressor activity
(Rastinejad et al., 1993
). However, an effect of the 3'UTR
of
-SMA on fibroblast contraction seems to be unlikely, because this
region was excluded from our actin cDNA constructs.
In conclusion, we have shown with the use of different approaches that
de novo expression of
-SMA in cultured fibroblasts enhances their
contractile activity. The direct evidence obtained from
-SMA cDNA
transfection experiments is corroborated by the results showing a
correlation between levels of
-SMA expression and cell contractility
in several other experimental situations. Apparently the
-SMA
activity is exerted without any change in myosin HC expression;
probably
-SMA provides more competent interaction with NMM either
directly or indirectly by generating an actin organization specialized
for contraction. Further studies along these lines may provide
important information on the cellular mechanisms regulating the
contraction of a healing wound and of fibrotic tissues.
| |
ACKNOWLEDGMENTS |
|---|
We thank Drs. S. Clément, C. von Ballestrem, O. Thoumine,
and Pr. Jean-Marc Meyer for their advice in transfection experiments, silicon assays, and on the use of dental resin; A. Maurer-Hiltbrunner for technical assistance; Messrs. J.C. Rumbeli and E. Denkinger for
photographic work; and Mrs. S. Josseron for secretarial work. This work
was supported by the Swiss National Science Foundation (grants
31-50568.97 and 31-54048.98) and by the Roche Research Foundation, F. Hoffmann-La Roche Ltd. (grant 98-206). Drs. David A. Cox, Victor
Koteliansky, Jean-Claude Perriard, and Luciano Zardi are gratefully
acknowledged for providing recombinant-human TGF
2, TGF
-sR and
rED-A, antitag antibodies, and IST-9 antibodies, respectively.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
Giulio.Gabbiani{at}medecine.unige.ch.
| |
ABBREVIATIONS |
|---|
Abbreviations used:
-SMA,
-smooth muscle actin;
FN, fibronectin;
HC, heavy chain;
LFs, lung fibroblast;
NMM, nonmuscle
myosin;
TGF
-sR, soluble TGF
-receptor type II;
PFA, paraformaldehyde;
rED-A, recombinant ED-A;
SCFs, subcutaneous
fibroblast;
SMM, smooth muscle myosin;
TX-100, triton X-100.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Y. Y. Yip, J.-H. Chen, R. Zhao, and C. A. Simmons Calcification by Valve Interstitial Cells Is Regulated by the Stiffness of the Extracellular Matrix Arterioscler. Thromb. Vasc. Biol., June 1, 2009; 29(6): 936 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sindrilaru, T. Peters, J. Schymeinsky, T. Oreshkova, H. Wang, A. Gompf, F. Mannella, M. Wlaschek, C. Sunderkotter, K. L. Rudolph, et al. Wound healing defect of Vav3-/- mice due to impaired {beta}2-integrin-dependent macrophage phagocytosis of apoptotic neutrophils Blood, May 21, 2009; 113(21): 5266 - 5276. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Jobling, A. Gentle, R. Metlapally, B. J. McGowan, and N. A. McBrien Regulation of Scleral Cell Contraction by Transforming Growth Factor-{beta} and Stress: COMPETING ROLES IN MYOPIC EYE GROWTH J. Biol. Chem., January 23, 2009; 284(4): 2072 - 2079. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Vaahtomeri, E. Ventela, K. Laajanen, P. Katajisto, P.-J. Wipff, B. Hinz, T. Vallenius, M. Tiainen, and T. P. Makela Lkb1 is required for TGF{beta}-mediated myofibroblast differentiation J. Cell Sci., November 1, 2008; 121(21): 3531 - 3540. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Liu and A. I. Gotlieb Transforming Growth Factor-{beta} Regulates in Vitro Heart Valve Repair by Activated Valve Interstitial Cells Am. J. Pathol., November 1, 2008; 173(5): 1275 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Follonier, S. Schaub, J.-J. Meister, and B. Hinz Myofibroblast communication is controlled by intercellular mechanical coupling J. Cell Sci., October 15, 2008; 121(20): 3305 - 3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ding, C. L. Gladson, H. Wu, H. Hayasaka, and M. A. Olman Focal Adhesion Kinase (FAK)-related Non-kinase Inhibits Myofibroblast Differentiation through Differential MAPK Activation in a FAK-dependent Manner J. Biol. Chem., October 3, 2008; 283(40): 26839 - 26849. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Valamehr, S. J. Jonas, J. Polleux, R. Qiao, S. Guo, E. H. Gschweng, B. Stiles, K. Kam, T.-J. M. Luo, O. N. Witte, et al. Hydrophobic surfaces for enhanced differentiation of embryonic stem cell-derived embryoid bodies PNAS, September 23, 2008; 105(38): 14459 - 14464. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meyer-ter-Vehn, B. Katzenberger, H. Han, F. Grehn, and G. Schlunck Lovastatin Inhibits TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3955 - 3960. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stepanova, T. Lebedeva, A. Kuo, S. Yarovoi, S. Tkachuk, S. Zaitsev, K. Bdeir, I. Dumler, M. S. Marks, Y. Parfyonova, et al. Nuclear translocation of urokinase-type plasminogen activator Blood, July 1, 2008; 112(1): 100 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Cushing, P. D. Mariner, J.-T. Liao, E. A. Sims, and K. S. Anseth Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells FASEB J, June 1, 2008; 22(6): 1769 - 1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Haydont, B. L. Riser, J. Aigueperse, and M.-C. Vozenin-Brotons Specific signals involved in the long-term maintenance of radiation-induced fibrogenic differentiation: a role for CCN2 and low concentration of TGF-{beta}1 Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1332 - C1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Huet, B. Vallee, D. Szul, F. Verrecchia, S. Mourah, J. V. Jester, T. Hoang-Xuan, S. Menashi, and E. E. Gabison Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing {alpha}-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling FASEB J, April 1, 2008; 22(4): 1144 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pittet, K. Lee, A. J. Kulik, J.-J. Meister, and B. Hinz Fibrogenic fibroblasts increase intercellular adhesion strength by reinforcing individual OB-cadherin bonds J. Cell Sci., March 15, 2008; 121(6): 877 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Dawes, J. A. Eldred, I. K. Anderson, M. Sleeman, J. R. Reddan, G. Duncan, and I. M. Wormstone TGF{beta}-Induced Contraction Is Not Promoted by Fibronectin-Fibronectin Receptor Interaction, or {alpha}SMA Expression Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 650 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schlunck, H. Han, T. Wecker, D. Kampik, T. Meyer-ter-Vehn, and F. Grehn Substrate Rigidity Modulates Cell Matrix Interactions and Protein Expression in Human Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 262 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-J. Wipff, D. B. Rifkin, J.-J. Meister, and B. Hinz Myofibroblast contraction activates latent TGF- 1 from the extracellular matrix J. Cell Biol., December 17, 2007; 179(6): 1311 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pellegrin and H. Mellor Actin stress fibres J. Cell Sci., October 15, 2007; 120(20): 3491 - 3499. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hinz, S. H. Phan, V. J. Thannickal, A. Galli, M.-L. Bochaton-Piallat, and G. Gabbiani The Myofibroblast: One Function, Multiple Origins Am. J. Pathol., June 1, 2007; 170(6): 1807 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Roos, N. Poulalhon, D. Farge, I. Madelaine, A. Mauviel, and F. Verrecchia In Vitro Evidence for a Direct Antifibrotic Role of the Immunosuppressive Drug Mycophenolate Mofetil J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 583 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yuge, K. Nasu, H. Matsumoto, M. Nishida, and H. Narahara Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis-associated fibrosis Hum. Reprod., April 1, 2007; 22(4): 938 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Clement, M. Stouffs, E. Bettiol, S. Kampf, K.-H. Krause, C. Chaponnier, and M. Jaconi Expression and function of {alpha}-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation J. Cell Sci., January 15, 2007; 120(2): 229 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takeji, T. Moriyama, S. Oseto, N. Kawada, M. Hori, E. Imai, and T. Miwa Smooth Muscle {alpha}-Actin Deficiency in Myofibroblasts Leads to Enhanced Renal Tissue Fibrosis J. Biol. Chem., December 29, 2006; 281(52): 40193 - 40200. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Nho, H. Xia, D. Diebold, J. Kahm, J. Kleidon, E. White, and C. A. Henke PTEN Regulates Fibroblast Elimination during Collagen Matrix Contraction J. Biol. Chem., November 3, 2006; 281(44): 33291 - 33301. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meyer-ter-Vehn, S. Sieprath, B. Katzenberger, S. Gebhardt, F. Grehn, and G. Schlunck Contractility as a Prerequisite for TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4895 - 4904. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. WONG and V. MUDERA Feedback Inhibition of High TGF-{beta}1 Concentrations on Myofibroblast Induction and Contraction by Dupuytren's Fibroblasts J Hand Surg Eur Vol., October 1, 2006; 31(5): 473 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kelly, J. Chakir, D. Vethanayagam, L.-P. Boulet, M. Laviolette, J. Gauldie, and P. M. O'Byrne Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. Chest, September 1, 2006; 130(3): 741 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Takizawa, T. C. Smith, T. Nebl, J. L. Crowley, S. J. Palmieri, L. M. Lifshitz, A. G. Ehrhardt, L. M. Hoffman, M. C. Beckerle, and E. J. Luna Supervillin modulation of focal adhesions involving TRIP6/ZRP-1 J. Cell Biol., July 31, 2006; 174(3): 447 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Munoz-Fernandez, F. J. Blanco, C. Frecha, F. Martin, M. Kimatrai, A. C. Abadia-Molina, J. M. Garcia-Pacheco, and E. G. Olivares Follicular Dendritic Cells Are Related to Bone Marrow Stromal Cell Progenitors and to Myofibroblasts J. Immunol., July 1, 2006; 177(1): 280 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Tomasek, C. J. Haaksma, R. J. Schwartz, D. T. Vuong, S. X. Zhang, J. D. Ash, J.-x. Ma, and M. R. Al-Ubaidi Deletion of Smooth Muscle {alpha}-Actin Alters Blood-Retina Barrier Permeability and Retinal Function. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2693 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meyer-ter-Vehn, S. Gebhardt, W. Sebald, M. Buttmann, F. Grehn, G. Schlunck, and P. Knaus p38 Inhibitors Prevent TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1500 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Goffin, P. Pittet, G. Csucs, J. W. Lussi, J.-J. Meister, and B. Hinz Focal adhesion size controls tension-dependent recruitment of {alpha}-smooth muscle actin to stress fibers J. Cell Biol., January 16, 2006; 172(2): 259 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Discher, P. Janmey, and Y.-l. Wang Tissue Cells Feel and Respond to the Stiffness of Their Substrate Science, November 18, 2005; 310(5751): 1139 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Ng, B. Hinz, and M. A. Swartz Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro J. Cell Sci., October 15, 2005; 118(20): 4731 - 4739. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zhang, X. Liu, J. G. Cogan, M. D. Fuerst, J. A. Polikandriotis, R. J. Kelm Jr., and A. R. Strauch YB-1 Coordinates Vascular Smooth Muscle {alpha}-Actin Gene Activation by Transforming Growth Factor {beta}1 and Thrombin during Differentiation of Human Pulmonary Myofibroblasts Mol. Biol. Cell, October 1, 2005; 16(10): 4931 - 4940. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tamaoki, K. Imanaka-Yoshida, K. Yokoyama, T. Nishioka, H. Inada, M. Hiroe, T. Sakakura, and T. Yoshida Tenascin-C Regulates Recruitment of Myofibroblasts during Tissue Repair after Myocardial Injury Am. J. Pathol., July 1, 2005; 167(1): 71 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamada, H. Kurihara, K. Kinoshita, and T. Sakai Temporal Expression of Alpha-Smooth Muscle Actin and Drebrin in Septal Interstitial Cells during Alveolar Maturation J. Histochem. Cytochem., June 1, 2005; 53(6): 735 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Tomasek, J. McRae, G. K. Owens, and C. J. Haaksma Regulation of {alpha}-Smooth Muscle Actin Expression in Granulation Tissue Myofibroblasts Is Dependent on the Intronic CArG Element and the Transforming Growth Factor-{beta}1 Control Element Am. J. Pathol., May 1, 2005; 166(5): 1343 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Georges and P. A. Janmey Cell type-specific response to growth on soft materials J Appl Physiol, April 1, 2005; 98(4): 1547 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Watts, E. M. Sampson, G. S. Schultz, and M. A. Spiteri Simvastatin Inhibits Growth Factor Expression and Modulates Profibrogenic Markers in Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 290 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, J. Fan, C. Laschinger, P. D. Arora, A. Kapus, A. Seth, and C. A. McCulloch Smooth Muscle Actin Determines Mechanical Force-induced p38 Activation J. Biol. Chem., February 25, 2005; 280(8): 7273 - 7284. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Watts and M. A. Spiteri Connective tissue growth factor expression and induction by transforming growth factor-{beta} is abrogated by simvastatin via a Rho signaling mechanism Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1323 - L1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Subramanian, J. A. Polikandriotis, R. J. Kelm Jr., J. J. David, C. G. Orosz, and A. R. Strauch Induction of Vascular Smooth Muscle {alpha}-Actin Gene Transcription in Transforming Growth Factor {beta}1-Activated Myofibroblasts Mediated by Dynamic Interplay between the Pur Repressor Proteins and Sp1/Smad Coactivators Mol. Biol. Cell, October 1, 2004; 15(10): 4532 - 4543. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hinz, P. Pittet, J. Smith-Clerc, C. Chaponnier, and J.-J. Meister Myofibroblast Development Is Characterized by Specific Cell-Cell Adherens Junctions Mol. Biol. Cell, September 1, 2004; 15(9): 4310 - 4320. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Walker, K. S. Masters, D. N. Shah, K. S. Anseth, and L. A. Leinwand Valvular Myofibroblast Activation by Transforming Growth Factor-{beta}: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease Circ. Res., August 6, 2004; 95(3): 253 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Thorey, B. Hinz, A. Hoeflich, S. Kaesler, P. Bugnon, M. Elmlinger, R. Wanke, E. Wolf, and S. Werner Transgenic Mice Reveal Novel Activities of Growth Hormone in Wound Repair, Angiogenesis, and Myofibroblast Differentiation J. Biol. Chem., June 18, 2004; 279(25): 26674 - 26684. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Shephard, G. Martin, S. Smola-Hess, G. Brunner, T. Krieg, and H. Smola Myofibroblast Differentiation Is Induced in Keratinocyte-Fibroblast Co-Cultures and Is Antagonistically Regulated by Endogenous Transforming Growth Factor-{beta} and Interleukin-1 Am. J. Pathol., June 1, 2004; 164(6): 2055 - 2066. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Garrett, P. T. Khaw, T. D. Blalock, G. S. Schultz, G. R. Grotendorst, and J. T. Daniels Involvement of CTGF in TGF-{beta}1-Stimulation of Myofibroblast Differentiation and Collagen Matrix Contraction in the Presence of Mechanical Stress Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1109 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zheng, H. Bando, Y. Ikuno, Y. Oshima, M. Sawa, M. Ohji, and Y. Tano Involvement of Rho-Kinase Pathway in Contractile Activity of Rabbit RPE Cells In Vivo and In Vitro Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 668 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, H. Chen, A. Seth, and C. A. McCulloch Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1871 - H1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Rice and L. A. Leinwand Skeletal myosin heavy chain function in cultured lung myofibroblasts J. Cell Biol., October 13, 2003; 163(1): 119 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lijnen, V. Petrov, and R. Fagard Transforming growth factor-{beta}1-mediated collagen gel contraction by cardiac fibroblasts Journal of Renin-Angiotensin-Aldosterone System, June 1, 2003; 4(2): 113 - 118. [Abstract] [PDF] |
||||
![]() |
B. Hinz, V. Dugina, C. Ballestrem, B. Wehrle-Haller, and C. Chaponnier {alpha}-Smooth Muscle Actin Is Crucial for Focal Adhesion Maturation in Myofibroblasts Mol. Biol. Cell, June 1, 2003; 14(6): 2508 - 2519. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ferri, K. J. Garton, and E. W. Raines An NF-{kappa}B-dependent Transcriptional Program Is Required for Collagen Remodeling by Human Smooth Muscle Cells J. Biol. Chem., May 23, 2003; 278(22): 19757 - 19764. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Calabrese, M. Zhang, V. Serre-Beinier, D. Caton, C. Mas, L. S. Satin, and P. Meda Connexin 36 Controls Synchronization of Ca2+ Oscillations and Insulin Secretion in MIN6 Cells Diabetes, February 1, 2003; 52(2): 417 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Cogan, S. V. Subramanian, J. A. Polikandriotis, R. J. Kelm Jr., and A. R. Strauch Vascular Smooth Muscle alpha -Actin Gene Transcription during Myofibroblast Differentiation Requires Sp1/3 Protein Binding Proximal to the MCAT Enhancer J. Biol. Chem., September 20, 2002; 277(39): 36433 - 36442. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Sun, Y. Fujigaki, T. Fujimoto, T. Goto, K. Yonemura, and A. Hishida Mycophenolate Mofetil Inhibits Regenerative Repair in Uranyl Acetate-Induced Acute Renal Failure by Reduced Interstitial Cellular Response Am. J. Pathol., July 1, 2002; 161(1): 217 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, M. Su, J. Fan, A. Seth, and C. A. McCulloch Transcriptional Regulation of a Contractile Gene by Mechanical Forces Applied through Integrins in Osteoblasts J. Biol. Chem., June 14, 2002; 277(25): 22889 - 22895. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hinz, G. Gabbiani, and C. Chaponnier The NH2-terminal peptide of {alpha}-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo J. Cell Biol., May 13, 2002; 157(4): 657 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.P. Brock, R. Marty-Roix, and M. Spector {alpha}-Smooth-muscle Actin in and Contraction of Porcine Dental Pulp Cells Journal of Dental Research, March 1, 2002; 81(3): 203 - 208. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||